Concepedia

Philip Fremont‐Smith

PF

Statistics

Publications

7

Citations

270

H-Index

7

Active since

2020

Affiliations

MIT Lincoln Laboratory(Current)

Quinnipiac University

Malone University

McGill University

University of North Carolina at Chapel Hill

Philip Fremont‐Smith is an author at MIT Lincoln Laboratory specializing in infectious diseases, pharmacotherapy, and inflammation.

ORCID

Publications per year

2020–2023

7

Publications

7

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

Robert W. Malone, Philip Tisdall, Philip Fremont‐Smith et al. · Frontiers in Pharmacology · 2021 · 105 citations · Full text

, , +17

Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients

Juan Ignacio Morán Blanco, Judith A. Alvarenga Bonilla, Sakae Homma et al. · Pulmonary Pharmacology & Therapeutics · 2021 · 71 citations · Full text

, , +12

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

Robert W. Malone, Philip Tisdall, Philip Fremont‐Smith et al. · 2020 · 27 citations · Full text

, , +17

Analysis of complex DNA mixtures using massively parallel sequencing of SNPs with low minor allele frequencies

Martha Petrovick, Tara Boettcher, Philip Fremont‐Smith et al. · Forensic Science International Genetics · 2020 · 24 citations

, , +14

Kawasaki Disease, Multisystem Inflammatory Syndrome in Children: Antibody-Induced Mast Cell Activation Hypothesis

Darrell Ricke, Nicole Gherlone, Philip Fremont‐Smith et al. · Journal of Pediatrics and Pediatric Medicine · 2020 · 15 citations · Full text

, , +17

1–5 of 7